Autoimmune Disorders: Gastrointestinal Manifestations and Endoscopic Findings

Gastrointestinal Endoscopy Clinics of North America

Volumn 16, Issue 1, 2006, Pages 133-151

  Schneider, Alison ^a   Merikhi, Afkhamossadat ^a   Frank, Barbara B ^a  

^a DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NONSTEROID ANTIINFLAMMATORY AGENT; SEX HORMONE;

AMYLOIDOSIS; ANAPHYLACTOID PURPURA; ANTIPHOSPHOLIPID SYNDROME; APHTHOUS ULCER; ATROPHIC GASTRITIS; AUTOIMMUNE DISEASE; BEHCET DISEASE; BUDD CHIARI SYNDROME; CLINICAL FEATURE; COLITIS; COLON ULCER; CROHN DISEASE; DERMATOMYOSITIS; DIARRHEA; DIFFERENTIAL DIAGNOSIS; DIVERTICULOSIS; DUODENUM ULCER; ENDOSCOPY; ESOPHAGUS INJURY; ESOPHAGUS VARICES; GASTROINTESTINAL HEMORRHAGE; GASTROINTESTINAL SYMPTOM; GINGIVITIS; HELICOBACTER PYLORI; HUMAN; HYPOALBUMINEMIA; INTESTINE INFARCTION; INTESTINE ISCHEMIA; INTESTINE OBSTRUCTION; INTESTINE PERFORATION; LYMPHOMA; NECROTIZING ARTERITIS; NONHUMAN; PATHOGENICITY; POLYARTERITIS NODOSA; PORTAL VEIN THROMBOSIS; PRIORITY JOURNAL; PROCTITIS; PROTEIN LOSING GASTROENTEROPATHY; PROTEINURIA; REVIEW; RHEUMATOID ARTHRITIS; SCLERODERMA; STOMACH DISEASE; SYSTEMIC LUPUS ERYTHEMATOSUS; TELANGIECTASIA; THROMBOEMBOLISM; VASCULITIS; VOLVULUS;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ARTHRITIS, RHEUMATOID; AUTOIMMUNE DISEASES; BEHCET SYNDROME; ENDOSCOPY, GASTROINTESTINAL; ESOPHAGITIS; FEMALE; GASTROINTESTINAL DISEASES; GASTROINTESTINAL MOTILITY; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIXED CONNECTIVE TISSUE DISEASE; SCLERODERMA, DIFFUSE; SEX FACTORS; SJOGREN'S SYNDROME; WEGENER GRANULOMATOSIS;

EID: 33646098666     PISSN: 10525157     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.giec.2006.01.013     Document Type: Review

References (111)

1. Beeson P.B. Age and sex associations of 40 autoimmune diseases. Am J Med 96 (1994) 457-462
2. Ansar Ahmed S., Dauphinee M.J., and Talal N. Effects of short-term administration of sex hormones on normal and autoimmune mice. J Immunol 134 (1985) 204-210
3. Roubinian J.R., Talal N., Greenspan J.S., et al. Effect of castration and sex hormone treatment on survival, anti-nucleic acid antibodies, and glomerulonephritis in NZB/NZW F1 mice. J Exp Med 147 (1978) 1568-1583
4. Buyon J.P., Petri M.A., Kim M.Y., et al. The effect of combined estrogen and progesterone hormone replacement therapy on disease activity in systemic lupus erythematosus: a randomized trial. Ann Intern Med 142 (2005) 953-962
5. Klippel J.H., Crofford L.J., and Stone J.H. Primer on the rheumatic diseases. 12th edition (2001), Arthritis Foundation, Atlanta
6. Jovaisas A., and Kraag G. Acute gastrointestinal manifestations of systemic lupus erythematosus. Can J Surg 30 (1987) 185-188
7. Vitali C., Doria A., Tincani A., et al. International survey on the management of patients with SLE. I. General data on the participating centers and the results of a questionnaire regarding mucocutaneous involvement. Clin Exp Rheumatol 14 Suppl 16 (1996) S17-S22
8. Gutierrez F., Valenzuela J.E., Ehresmann G.R., et al. Esophageal dysfunction in patients with mixed connective tissue diseases and systemic lupus erythematosus. Dig Dis Sci 27 (1982) 592-597
9. Fitzgerald R.C., and Triadafiliopoulos G. Esophageal manifestations of rheumatic disorders. Semin Arthritis Rheum 26 (1997) 641-666
10. Messer J., Reitman D., Sacks H.S., et al. Association of adrenocorticosteroid therapy and peptic-ulcer disease. N Engl J Med 309 (1983) 21-24
11. Archimandritis A., Tsirantonaki M., Tzivras M., et al. Watermelon stomach in a patient with vitiligo and systemic lupus erythematosus. Clin Exp Rheum 14 (1996) 227-228
12. Hallegua D.S., and Wallace D. Gastrointestinal manifestations of systemic lupus erythematosus. Curr Opin Rheum 12 (2000) 379-385
13. Medina F., Ayala A., Jara L.J., et al. Acute abdomen in systemic lupus erythematosus: the importance of early laparotomy. Am J Med 103 (1997) 100-105
14. Zizic T.M., Shulman L.E., and Stevens M.B. Colonic perforations in systemic lupus erythematosus. Medicine 54 (1975) 411-426
15. Tsuchiya M., Okazaki I., Asakura H., et al. Radiographic and endoscopic features of colonic ulcers in systemic lupus erythematosus. Am J Gastroenterol 64 (1975) 277-285
16. Sasamura H., Nakamoto H., Ryuzaki M., et al. Repeated intestinal ulcerations in a patient with systemic lupus erythematosus and high serum antiphospholipid antibody levels. South Med J 84 (1991) 515-517
17. Grimbacher B., Huber M., Kempis J., et al. Successful treatment of gastrointestinal vasculitis due to systemic lupus erythematosus with intravenous pulse cyclophosphamide: a clinical case report and review of the literature. Br J Rheumatol 37 (1998) 1023-1028
18. Kleinman P., Meyers M.A., Abbott G., et al. Necrotizing enterocolitis with pneumatosis intestinalis in systemic lupus erythematosus and polyarteritis. Radiology 121 (1976) 595-598
19. Cabrera G.E., Scopelitis E., Cuellar M.L., et al. Pneumatosis cystoides intestinalis in systemic lupus erythematosus with intestinal vasculitis: treatment with high dose prednisone. Clin Rheumatol 13 (1994) 312-316
20. Amit G., Stalnikowicz R., Ostrovsky Y., et al. Rectal ulcers: a rare gastrointestinal manifestation of systemic lupus erythematosus. J Clin Gastroenterol 29 (1999) 200-202
21. Sunheimer R.L., Finck C., Mortazavi S., et al. Primary lupus-associated protein-losing enteropathy. Ann Clin Lab Sci 24 (1994) 239-242
22. Weisman M.H., McDanald E.C., and Wilson C.B. Studies of the pathogenesis of interstitial cystitis, obstructive uropathy, and intestinal malabsorption in a patient with systemic lupus erythematosus. Am J Med 70 (1981) 875-881
23. Pelletier S., Ekert P., Landi B., et al. Exudative enteropathy in disseminated lupus erythematosus. Ann Gastroenterol Hepatol (Paris) 28 (1992) 259-262
24. Perlemuter G., Chaussade S., Wechsler B., et al. Chronic intestinal pseudo-obstruction in systemic lupus erythematosus. Gut 43 (1998) 117-122
25. Mok M.Y., Wong R.W., and Lau C.S. Intestinal pseudo-obstruction in systemic lupus erythematosus: an uncommon but important clinical manifestation. Lupus 9 (2000) 11-18
26. Kalman D.R., Khan A., Romain P.L., et al. Giant Gastric ulceration associated with antiphospholipid antibody syndrome. Am J Gastroenterol 91 (1996) 1244-1247
27. Clerck L.S., Michielsen P.P., Ramael M.R., et al. Portal and pulmonary vessel thrombosis associated with systemic lupus erythematosus and anticardiolipin antibodies. J Rheumatol 18 (1991) 1919-1921
28. Ordi J., Vargas V., Vilardell M., et al. Lupus anticoagulant and portal hypertension. Am J Med 84 (1988) 566-567
29. Cappell M. Esophageal necrosis and perforation associated with the anticardiolipin antibody syndrome. Am J Gastroenterol 89 (1994) 1241-1245
30. Edworthy S. Clinical manifestations of systemic lupus erythematosus. In: Harris E.D., Budd R.C., Genovese M.C., et al. (Eds). Kelley's textbook of rheumatology. 7th edition (2005), WB Saunders, Philadelphia 1201-1224
31. Young M.A., Rose S., and Reynolds J.C. Gastrointestinal manifestations of scleroderma. Rheum Dis Clin North Am 22 (1996) 797-823
32. Lock G., Holstege A., Lang B., et al. Gastrointestinal manifestations of progressive systemic sclerosis. Am J Gastroenterol 92 (1997) 763-771
33. Rohrmann Jr. C.A., Ricci M.T., Krishnamurthy S., et al. Radiologic and histologic differentiation of neuromuscular disorders of the gastrointestinal tract: visceral myopathies, visceral neuropathies, and progressive systemic sclerosis. AJR Am J Roentgenol 143 (1984) 933-941
34. Zaninotto G., Peserico A., Costantini M., et al. Oesophageal motility and lower oesophageal sphincter competence in progressive systemic sclerosis and localized scleroderma. Scand J Gastroenterol 24 (1989) 95-102
35. Treacy W.L., Baggenstoss A.H., Slocumb C.H., et al. Scleroderma of the esophagus: a correlation of histologic and physiologic findings. Ann Intern Med 59 (1963) 351-356
36. Rose S., Young M.A., and Reynolds J.C. Gastrointestinal manifestations of scleroderma. Gastroenterol Clin North Am 27 (1998) 563-594
37. Murphy J.R., McInally P., Peller P., et al. Prolonged clearance is the primary abnormal reflux parameter in patients with progressive systemic sclerosis and esophagitis. Dig Dis Sci 37 (1992) 833-841
38. Zamost B.J., Hirschberg J., Ippoliti A.F., et al. Esophagitis in scleroderma: prevalence and risk factors. Gastroenterology 92 (1987) 421-428
39. Barnett J.L. Vascular ectasia of the gastric antrum. N Engl J Med 339 (1998) 164-165
40. Mapp E. Colonic manifestations of the connective tissue disorders. Am J Gastroenterol 75 (1981) 386-393
41. Schuffler M.D., Rohrmann C.A., Chaffee R.G., et al. Chronic intestinal pseudo-obstruction: a report of 27 cases and review of the literature. Medicine 60 (1981) 173-196
42. Chiou A.W.H., Lin J.K., and Wang F.W. Anorectal abnormalities in progressive systemic sclerosis. Dis Colon Rectum 32 (1989) 417-421
43. Leighton J.A., Valdovinos M.A., Pemberton J.H., et al. Anorectal dysfunction and rectal prolapse in progressive systemic sclerosis. Dis Colon Rectum 36 (1993) 182-185
44. Singh D., Shill M., and Kaur H. The watermelon rectum. J Clin Gastroenterol 33 (2001) 164-166
45. Harris E. Clinical features of rheumatoid arthritis. In: Harris E.D., Budd R.C., Genovese M.C., et al. (Eds). Kelley's textbook of rheumatology. 7th edition (2005), WB Saunders, Philadelphia 1043-1078
46. Bassotti G., Gaburri M., Biscarini L., et al. Oesophageal motor activity in rheumatoid arthritis: a clinical and manometric study. Digestion 39 (1988) 144-150
47. Klofkorn R.W., Steigerwald J.C., Mills D.M., et al. Esophageal varices in Felty's syndrome. Arthritis Rheum 19 (1976) 150-154
48. Estrada C.A., Lewandowski C., Schubert T.T., et al. Esophageal involvement in secondary amyloidosis mimicking achalasia. J Clin Gastroenterol 12 (1990) 447-450
49. Laine L., Bombardier C., Hawkey C.J., et al. Stratifying the risk of NSAID-related upper gastrointestinal clinical events: result of a double-blind outcomes study in patients with rheumatoid arthritis. Gastroenterology 123 (2002) 1006-1012
50. Chan F.K.L., Sung J.J.Y., Chung S.C.S., et al. Randomised trial of eradication of Helicobacter pylori before non-steroidal anti-inflammatory drug therapy to prevent peptic ulcers. Lancet 350 (1997) 975-979
51. Larkai E.N., Smith J.L., Lidsky M.D., et al. Gastroduodenal mucosa and dyspeptic symptoms in arthritic patients during chronic nonsteroidal anti-inflammatory drug use. Am J Gastroenterol 82 (1987) 1153-1158
52. Voskuyl A.E., Van de Laar M.A., Moens H.J., et al. Extra-articular manifestations of rheumatoid arthritis: risk factors for serious gastrointestinal events. Ann Rheum Dis 52 (1993) 771-775
53. Burt R.W., Berenson M.M., Samuelson C.O., et al. Rheumatoid vasculitis of the colon presenting as pancolitis. Dig Dis Sci 28 (1993) 183-188
54. Kawaguchi M., Koizumi F., Shimao M., et al. Protein-losing enteropathy due to secondary amyloidosis of the gastrointestinal tract. Acta Pathol Jpn 43 (1993) 333-339
55. Moutsopoulos H.M., Chused T.M., Mann D.L., et al. Sjögren's syndrome (sicca syndrome): current issues. Ann Intern Med 92 (1980) 212-226
56. Pillemer S.R., Matteson E.L., Jacobsson L.T., et al. Incidence of physician-diagnosed primary Sjögren's syndrome in residents of Olmsted County, Minnesota. Mayo Clin Proc 76 (2001) 593-599
57. Talal N. Sjögren's syndrome and connective tissue disease associated with other immunologic disorders. In: McCarty D.J. (Ed). Arthritis and allied conditions, vol 2. 12th edition (1989), Lea & Febiger, Philadelphia 1197-1213
58. Valdez I.H., and Fox P.C. Interactions of the salivary and gastrointestinal systems. II. Effects of salivary gland dysfunction on the gastrointestinal tract. Dig Dis 9 (1991) 210-218
59. Volter F., Fain O., Mathieu E., et al. Esophageal function and Sjögren's syndrome. Dig Dis Sci 49 (2004) 248-253
60. Constantopoulos S.H., Tsianos E.V., and Moutsopoulos H.M. Pulmonary and gastrointestinal manifestations of Sjögren's syndrome. Rheum Dis Clin North Am 18 (1992) 617-635
61. Biagini M.R., Milani S., Fedi P., et al. Duodenal ulcer and Sjögren's syndrome in patients with primary biliary cirrhosis: a casual association. Am J Gastroenterol 86 (1991) 1190-1193
62. Masaki Y., and Sugai S. Lymphoproliferative disorders in Sjögren's syndrome. Autoimmun Rev 3 (2004) 175-182
63. Hoffman G.S., Kerr G.S., Leavitt R.Y., et al. Wegener's granulomatosis: an analysis of 158 patients. Ann Intern Med 116 (1992) 488-498
64. Tokuda M., Kurata N., Daikuhara H., et al. Small intestinal perforation in Wegener's granulomatosis. J Rheumatol 16 (1989) 547-549
65. Pinkney J.H., Clarke G., and Fairclough P.D. Gastrointestinal involvement in Wegener's granulomatosis. Gastrointest Endosc 37 (1991) 411-412
66. Uribe A., Goohar J., and Rubio C. Colonic ulceration in Wegener's granulomatosis. J Rheumatol 18 (1991) 1429-1430
67. Kemp J.A., Aroru S., and Fawaz K. Recurrent acute pancreatitis as a manifestation of Wegener's granulomatosis. Dig Dis Sci 35 (1990) 912-915
68. Allen C.M., Camisa C., Salewski C., et al. Wegener's granulomatosis: report of three cases with oral lesions. J Oral Maxillofac Surg 49 (1991) 294-298
69. Spiera R.F., Filippa D.A., Bains M.S., et al. Esophageal involvement in Wegener's granulomatosis. Arthritis Rheum 37 (1994) 1404-1407
70. Fallows G.A., Hamilton S.F., Taylor D.S., et al. Esophageal involvement in Wegener's granulomatosis: a case report and review of the literature. Can J Gastroenterol 14 (2000) 449-451
71. Temmesfeld-Wollbrueck B., Heinrichs C., Szalay A., et al. Granulomatous gastritis in Wegener's disease: differentiation from Crohn's disease supported by a positive test for antineutrophil antibodies. Gut 40 (1997) 550-553
72. Geraghty J., Mackay I.R., and Smith D.C. Intestinal perforation in Wegener's granulomatosis. Gut 27 (1986) 450-451
73. Haworth S.J., and Pusey C.D. Severe intestinal involvement in Wegener's granulomatosis. Gut 25 (1984) 1296-1300
74. Sackier J.M., Kelly S.B., Clark D., et al. Small bowel hemorrhage due to CMV vasculitis. Gut 32 (1991) 1419-1420
75. Aymard B., Bigard M.A., Thompson H., et al. Perianal ulcer: an unusual presentation of Wegener's granulomatosis. Dis Colon Rectum 33 (1990) 427-430
76. Sakane T., Takeno M., Suzuki N., et al. Behçet's disease. N Engl J Med 341 (1999) 1284-1291
77. Alva S. Colorectal manifestations of collagen vascular disease. Am J Surg 189 (2005) 685-693
78. Fujita H., Kiriyama M., Kawamura T., et al. Massive hemorrhage in a patient with intestinal Behcet's disease: report of a case. Surg Today 32 (2002) 378-382
79. Kim J.S., Lim S.H., and Choi I.J. Prediction of the clinical course of Behçet's colitis according to macroscopic classification by colonoscopy. Endoscopy 32 (2000) 635-640
80. Ghate J.V., and Jorizzo J.L. Behçet's disease and complex aphthosis. J Am Acad Dermatol 40 (1999) 1-8
81. McCarty M.A., Garton R.A., and Jorizzo J.L. Complex aphthosis and Behçet's disease. Dermatol Clin 21 (2003) 41-48
82. Yashiro K., Nagasako K., Hasegawa K., et al. Esophageal lesions in intestinal Behçet's disease. Endoscopy 18 (1986) 57-60
83. Sayek I., Aran O., Uzunalimoglu B., et al. Intestinal Behçet's disease: surgical experience in seven cases. Hepatogastroenterology 38 (1991) 81-83
84. Bayraktar Y., Ozaslan E., and Van Thiel D.H. Gastrointestinal manifestations of Behçet's disease. J Clin Gastroenterol 30 (2000) 144-154
85. Bottomley W.W., Dakkak M., Walton S., et al. Esophageal involvement in Behçet's disease. Is endoscopy necessary?. Dig Dis Sci 37 (1992) 594-597
86. Ormeci N., Gurler A., and Cakir M. Prevalence of H. pylori in Behçet's disease. VIIth International Conference on Behçet's Disease [abstract J14]. Rev Rhum Engl Ed 63 (1996) 558
87. Ozenc A., Bayraktar Y., and Baykal A. Pyloric stenosis with esophageal involvement in Behçet's syndrome. Am J Gastroenterol 85 (1990) 727-728
88. Ng F.H., Cheung T.C., Chow K.C., et al. Repeated intestinal perforation caused by an incomplete form of Behçet's syndrome. J Gastroenterol Hepatol 16 (2001) 935-939
89. Choi I.J., Kim J.S., Cha S.D., et al. Long-term clinical course and prognostic factors in intestinal Behçet's disease. Dis Colon Rectum 43 (2000) 692-700
90. Jennette J.C., Falk R.J., Andrassy K., et al. Nomenclature of systemic vasculitides: proposal of an international consensus conference. Arthritis Rheum 37 (1994) 187-192
91. Bailey M., Chapin W., Licht H., et al. The effects of vasculitis on the gastrointestinal tract and liver. Gastroenterol Clin North Am 27 (1998) 747-782
92. Nathan K., Gunasekaran T.S., and Berman J.H. Recurrent gastrointestinal Henoch-Schönlein purpura. J Clin Gastroenterol 29 (1999) 86-89
93. Esaki M., Matsumoto T., Nakamura S., et al. GI involvement in Henoch-Schönlein purpura. Gastrointest Endosc 56 (2002) 920-923
94. Chen M.J., Wang T.E., Chang W.H., et al. Endoscopic findings in a patient with Henoch-Schönlein purpura. World J Gastroenterol 11 (2005) 2354-2356
95. Pore G. GI lesions in Henoch-Schönlein purpura. Gastrointest Endosc 55 (2002) 283-286
96. Ortego-Centeno N., Callejas-Rubio J.L., Lopez-Manas J.G., et al. Ileitis terminalis in a patient with Henoch-Schönlein purpura. Dig Dis Sci 44 (1999) 1590-1593
97. Kim H.S., Lee D.K., Baik S.K., et al. Ileal vasculitis in Henoch-Schönlein purpura. Gastrointest Endosc 54 (2001) 493-494
98. Nakasone H., Hokama A., Fukuchi J., et al. Colonoscopic findings in an adult patient with Henoch-Schönlein purpura. Gastrointest Endosc 52 (2000) 392
99. Ilona S.S. Henoch-Schönlein purpura: when and how to treat. J Rheumatol 19 (1996) 434-436
100. Guillevin L., Lhote F., Gallais V., et al. Gastrointestinal tract involvement in polyarteritis nodosa and Churg-Strauss syndrome. Ann Med Interne (Paris) 146 (1995) 260-267
101. Schmidt W.A. Use of imaging studies in the diagnosis of vasculitis. Curr Rheumatol Rep 6 (2004) 203-211
102. Dalakas M.C., and Hohfeld R. Polymyositis and dermatomyositis. Lancet 362 (2003) 971-982
103. Mebazaa A., Boussen H., and Nouira R. Dermatomyositis and malignancy in Tunisia: a multicenter national retrospective study of 20 cases. J Am Acad Dermatol 48 (2003) 530-534
104. Eshraghi N., Farahmand M., Maerz L.L., et al. Adult-onset dermatomyositis with severe gastrointestinal manifestations: case report and review of the literature. Surgery 123 (1998) 356
105. Callen J.P. Relation between dermatomyositis and polymyositis and cancer. Lancet 357 (2001) 85-86
106. Sharp G.C., Irvine W.S., May C.M., et al. Association of antibodies to ribonucleoprotein and Sm antigens and mixed connective tissue disease, systemic lupus erythematosus and other rheumatic diseases. N Engl J Med 295 (1976) 1149-1154
107. Marshall J.B., Kretschmar J.M., Gerhardt D.C., et al. Gastrointestinal manifestations of mixed connective tissue disease. Gastroenterology 98 (1990) 1232-1238
108. Norman D.A., and Fleischmann R.M. Gastrointestinal systemic sclerosis in serologic mixed connective tissue disease. Arthritis Rheum 21 (1978) 811-819
109. Cook C.L., and Lurie H.I. Case report: fatal gastrointestinal hemorrhage in mixed connective tissue disease. Arthritis Rheum 20 (1977) 1421-1427
110. Samach M., Brandt L.J., and Bernstein L.H. Spontaneous pneumoperitoneum with pneumatosis cystoides intestinalis in a patient with mixed connective tissue disease. Am J Gastroenterol 69 (1978) 494-500
111. Pagnoux C., Mahr A., Cohen P., et al. Presentation and outcome of gastrointestinal involvement in systemic necrotizing vasculitides: analysis of 62 patients with polyarteritis nodosa, microscopic polyangiitis, Wegener granulomatosis. Churg-Strauss syndrome, or rheumatoid arthritis-associated vasculitis. Medicine 84 (2005) 115-128